Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rocio Lavado-Valenzuela"'
Autor:
Tamara Díaz-Redondo, Rocio Lavado-Valenzuela, Begoña Jimenez, Tomas Pascual, Fernando Gálvez, Alejandro Falcón, Maria del Carmen Alamo, Cristina Morales, Marta Amerigo, Javier Pascual, Alfonso Sanchez-Muñoz, Macarena González-Guerrero, Luis Vicioso, Aurora Laborda, Maria Victoria Ortega, Lidia Perez, Aranzazu Fernandez-Martinez, Nuria Chic, Jose Manuel Jerez, Martina Alvarez, Aleix Prat, Nuria Ribelles, Emilio Alba
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Double blockade with pertuzumab and trastuzumab combined with chemotherapy is the standard neoadjuvant treatment for HER2-positive early breast cancer. Data derived from clinical trials indicates that the response rates differ among intri
Externí odkaz:
https://doaj.org/article/fe8078c1740f424c8825a31c4ca52cfb
Autor:
Alfonso Alba-Bernal, Ana Godoy-Ortiz, María Emilia Domínguez-Recio, Esperanza López-López, María Elena Quirós-Ortega, Victoria Sánchez-Martín, María Dunia Roldán-Díaz, Begoña Jiménez-Rodríguez, Jesús Peralta-Linero, Estefanía Bellagarza-García, Laura Troyano-Ramos, Guadalupe Garrido-Ruiz, M. Isabel Hierro-Martín, Luis Vicioso, Álvaro González-Ortiz, Noelia Linares-Valencia, Jesús Velasco-Suelto, Guillermo Carbajosa, Alicia Garrido-Aranda, Rocío Lavado-Valenzuela, Martina Álvarez, Javier Pascual, Iñaki Comino-Méndez, Emilio Alba
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Early breast cancer patients often experience relapse due to residual disease after treatment. Liquid biopsy is a methodology capable of detecting tumor components in blood, but low concentrations at early stages pose challenges. To detect t
Externí odkaz:
https://doaj.org/article/bd142254ea644db1a1eebb2a629ad70a
Autor:
Miguel Angel Berciano-Guerrero, Rocio Lavado-Valenzuela, Ismael Navas-Delgado, José F. Aldana-Montes, Alicia Fernandez-Rovira
Publikováno v:
RIUMA. Repositorio Institucional de la Universidad de Málaga
instname
instname
Melanoma is a highly immunogenic tumor. Therefore, in recent years physicians have incorporated drugs that alter the immune system into their therapeutic arsenal against this disease, revolutionizing in the treatment of patients in an advanced stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee805632a9251682fb81938bd1973f80
http://orcid.org/0000-0001-7819-5416
http://orcid.org/0000-0001-7819-5416
Autor:
Carlos Pagés, Rocio Lavado-Valenzuela, Miguel Angel Berciano, Jose Luis De la Cruz, Manuel Cobo, Cynthia Robles, Dolores Bautista, Roberto Mongil, Enrique Bermejo, Manuel Benavides, Francisco Páez, Ricardo Arrabal
Publikováno v:
Cancer Research. 73:A36-A36
Introduction and objective. Quantifying and comparing the degree of methylation in the promoter region of APC gene and coding region of FHIT gene in patients (p) with non small cell lung cancer (NSCLC) in different samples. Correlate these methylatio
Autor:
Roberto Mongil, Manuel Benavides, Cynthia Robles, Carlos Pagés, Dolores Bautista, Ricardo Arrabal, Miguel Angel Berciano, Jose Luis De la Cruz, Manuel Cobo, Rocio Lavado-Valenzuela, Enrique Bermejo, Francisco Páez
Publikováno v:
Cancer Research. 73:C20-C20
Introduction and objective. To evaluate and compare quantitatively aberrant methylation in the promoter area of EGFR gene in patients (p) with in non small cell lung cancer (NSCLC) lung tumor tissue (TT), lung normal tissue (NT), blood (B), bronchial
Autor:
Alfonso Alba-Bernal, Rocío Lavado-Valenzuela, María Emilia Domínguez-Recio, Begoña Jiménez-Rodriguez, María Isabel Queipo-Ortuño, Emilio Alba, Iñaki Comino-Méndez
Publikováno v:
EBioMedicine, Vol 62, Iss , Pp 103100- (2020)
Breast cancer is the most common cancer type in women worldwide and its early detection is crucial to curing the disease. Tissue biopsy, currently the method of choice to obtain tumour molecular information, is invasive and might be affected by tumou
Externí odkaz:
https://doaj.org/article/4b5c9fb4fc5f43238fa88923257f0b64
Autor:
Miguel-Angel Berciano-Guerrero, Rocío Lavado-Valenzuela, Aurelio Moya, Luis delaCruz-Merino, Fátima Toscano, Javier Valdivia, Victoria Castellón, Fernando Henao-Carrasco, Pilar Sancho, Juan-Luis Onieva-Zafra, Ismael Navas-Delgado, Antonio Rueda-Dominguez, Elisabeth Perez-Ruiz, Emilio Alba
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 284 (2022)
Targeted therapy in metastatic melanoma often achieves a major tumour regression response and significant long-term survival via the release of antigens that reinduce immunocompetence. The biomarkers thus activated may guide the prediction of respons
Externí odkaz:
https://doaj.org/article/18a4039dc9494c71a63c0c1a8eff1060